Evidence map›Paper›PMID 20065081›Full record

ArticleHaematologica2010

Rac1 and Rac2 GTPases are necessary for early erythropoietic expansion in the bone marrow but not in the spleen.

Theodosia A Kalfa, Suvarnamala Pushkaran, Xiaoling Zhang, James F Johnson, Dao Pan, Deidre Daria, Hartmut Geiger, Jose A Cancelas, David A Williams, Yi Zheng

Open access · goldAbstract readComparative Study
In one paragraph

Article in Haematologica, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Mouse Models of Erythropoiesis and Associated Diseases.Methods in molecular biology (Clifton, N.J.) · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Rho GTPases in erythroid maturation.Current opinion in hematology · 2014
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Theodosia A KalfaDivision of Hematology/Oncology, Oncology, Cincinnati Children's Research Foundation, Cincinnati Children's Hospital Medical Center, MLC 7015 Cincinnati, OH 45229-3039, USA. theodosia.kalfa@cchmc.org
Suvarnamala Pushkaran
Xiaoling Zhang
James F Johnson
Dao Pan
Deidre Daria
Hartmut Geiger
Jose A Cancelas
David A Williams
Yi Zheng
International Society for Experimental Hematology · USHospital Research Foundation · AUBoston Children's Hospital · USCincinnati Children's Hospital Medical Center · US

Funding

Translational project: Gene therapy for Sickle Cell DiseaseU54HL070871 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI PARTIN-WELCH, POLLY · 2003 to 2011
$16.4M
Rac proteins in hematopoietic cell survival and functionR01DK062757 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI WILLIAMS, DAVID A · 2002 to 2016
$5.7M
Rac GTPases as Targets in LymphomagenesisR01CA125658 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2007 to 2011
$2.1M
Genetic Therapy for CNS Manifestations in MPS I via BBB-targeted Protein DeliveryR01NS064330 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI PAN, DAO · 2008 to 2012
$1.6M
Rac1 and Rac2 Guanosine Triphosphatases in Erythroid Function and DifferentiationK08HL088126 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI KALFA, THEODOSIA ANASTASIOS · 2008 to 2012
$643k
In Vivo BM Stem Cell Gene Transfer for MPS type IR21AI061703 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI PAN, DAO · 2005 to 2006
$404k
NCI NIH HHS R01 CA125658NHLBI NIH HHS K08 HL088126NHLBI NIH HHS U54 HL070871NHLBI NIH HHS U54HL70871NIAID NIH HHS R21 AI061703NIDDK NIH HHS DK62757NIDDK NIH HHS R01 DK062757NINDS NIH HHS R01 NS064330
6 · The paper itself

Abstract

backgroundThe small Rho GTPases Rac1 and Rac2 have both overlapping and distinct roles in actin organization, cell survival, and proliferation in various hematopoietic cell lineages. The role of these Rac GTPases in erythropoiesis has not yet been fully elucidated. DESIGN AND

methodsCre-recombinase-induced deletion of Rac1 genomic sequence was accomplished on a Rac2-null genetic background, in mouse hematopoietic cells in vivo. The erythroid progenitors and precursors in the bone marrow and spleen of these genetically engineered animals were evaluated by colony assays and flow cytometry. Apoptosis and proliferation of the different stages of erythroid progenitors and precursors were evaluated by flow cytometry.

resultsErythropoiesis in Rac1(-/-);Rac2(-/-) mice is characterized by abnormal burst-forming unit-erythroid colony morphology and decreased numbers of megakaryocyte-erythrocyte progenitors, erythroid colony-forming units, and erythroblasts in the bone marrow. In contrast, splenic erythropoiesis is increased. Combined Rac1 and Rac2 deficiency compromises proliferation of the megakaryocyte-erythrocyte progenitor population in the bone marrow, while it allows increased survival and proliferation of megakaryocyte-erythrocyte progenitors in the spleen. Conclusions These data suggest that Rac1 and Rac2 GTPases are essential for normal bone marrow erythropoiesis but that they are dispensable for erythropoiesis in the spleen, implying different signaling pathways for homeostatic and stress erythropoiesis.

Indexed as

AnimalsBone Marrow CellsErythroblastsErythropoiesisGTP PhosphohydrolasesMiceMice, Inbred C57BLMice, TransgenicNeuropeptidesOrgan Specificityrac1 GTP-Binding ProteinRAC2 GTP-Binding Proteinrac GTP-Binding ProteinsSpleenTime FactorsGTP PhosphohydrolasesNeuropeptidesrac1 GTP-Binding ProteinRac1 protein, mouseRAC2 GTP-Binding Proteinrac GTP-Binding Proteins

Identifiers

PMID20065081
PMCPMC2805739
OpenAlexW2002980224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.